40 min listen
Novel Immunotherapies in Relapsed/Refractory Multiple Myeloma: What Does the Future Hold?
FromKeeping Current
Novel Immunotherapies in Relapsed/Refractory Multiple Myeloma: What Does the Future Hold?
FromKeeping Current
ratings:
Length:
35 minutes
Released:
Aug 3, 2021
Format:
Podcast episode
Description
Join Drs Leleu, Krishnan, and Rodriquez Otero discussing the immunotherapy highlights presented at the summer conferences. Credit available for this activity expires: 8/2/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/955670?src=mkm_podcast_addon_955670
Released:
Aug 3, 2021
Format:
Podcast episode
Titles in the series (100)
Implementing Multiple Myeloma Clinical Trial Data in Real-World Practice: Experts in the field discuss how to implement the newest data in multiple myeloma into the real-world clinical practice. --- Full URLs: Earn Credit / Learning Objectives & Disclosures:... by Keeping Current